The NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines Panel issued several updates to the guidelines in August 2021. Revisions include new recommendations for the therapeutic management of hospitalized adults with COVID-19, a statement on the Emergency Use Authorization of casirivimab plus imdevimab as postexposure prophylaxis for SARS-CoV-2, and information on the use of inhaled corticosteroids in non-hospitalized patients with COVID-19.

More information on the revisions to the COVID-19 treatment guidelines is available at www.covid19treatmentguidelines.nih.gov/about-the-guidelines/whats-new.